n-methylaspartate has been researched along with tat-nr2b9c in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, J; Gladding, CM; Kaufman, AM; Milnerwood, AJ; Raymond, LA; Wang, L; Zhang, LY | 1 |
1 other study(ies) available for n-methylaspartate and tat-nr2b9c
Article | Year |
---|---|
P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Bacterial Proteins; Cerebral Cortex; Chromosomes, Artificial, Yeast; Coculture Techniques; Corpus Striatum; Disease Models, Animal; Disks Large Homolog 4 Protein; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Guanylate Kinases; Humans; Huntingtin Protein; Huntington Disease; Immunoprecipitation; In Situ Nick-End Labeling; Luminescent Proteins; Membrane Proteins; Mice; Mice, Transgenic; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Peptides; Receptors, N-Methyl-D-Aspartate; Subcellular Fractions | 2012 |